Skip to main content

Clearlake Capital-Backed Provation Acquires ePreop

Written by Customer Service on . Posted in Mergers And Acquisitions.

Minneapolis, MN and Santa Monica, CA, Sept. 16, 2020 (GLOBE NEWSWIRE) — Provation, the premier software provider of procedure documentation and clinical decision support solutions, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”), today announced its acquisition of ePreop, a leading provider of perioperative SaaS solutions designed to simplify the entire surgical encounter.For 25 years, Provation has been a market leader in procedure documentation software for gastroenterology (“GI”), serving 43 of the top 50 GI hospitals and nearly 3,500 facilities nationwide. ePreop has been providing anesthesia quality reporting and perioperative care coordination solutions for more than 10 years and serves more than 18,000 end users and 1,500 facilities with its SurgicalValet™ and AnesthesiaValet™ platforms. The combination further expands Provation’s portfolio of clinical productivity solutions for hospitals and ASCs, while establishing a single comprehensive platform that streamlines preoperative screening, evidence-based care coordination, procedure documentation, coding, and reimbursement.“We are thrilled to welcome the ePreop team to the Provation family. ePreop adds critical perioperative care and reporting components to our capabilities and further advances our vision of empowering healthcare providers with innovative clinical productivity solutions,” said Daniel Hamburger, CEO of Provation. “Through organic and inorganic initiatives, we have developed a comprehensive portfolio of solutions that improves patient care and outcomes.” “Today marks an important milestone for ePreop,” added David Bergman, CEO and Founder of ePreop. “We are very excited to join the Provation team and are confident that this partnership will enable us to continue to build on our long history of serving physicians with industry-leading solutions. Collectively, we have some of the most passionate professionals in the healthcare IT industry and we are excited to work with the Provation team to develop technology to better serve our healthcare community.”“We believe in Provation’s vision to establish an integrated software platform of clinical productivity solutions, and look forward to continuing to support the Provation management team as they execute on their buy-and-build strategy, leveraging technology and innovation to better meet the evolving needs of healthcare professionals,” said Prashant Mehrotra and Paul Huber of Clearlake.Healthcare Growth Partners served as the financial advisor and Alston & Bird served as legal advisor to ePreop for this transaction. District Capital Partners served as financial advisor and Sidley Austin LLP served as legal advisor to Provation.About ProvationProvation Software Group, Inc. (“Provation”) is a leading provider of clinical productivity software for healthcare professionals, with solutions for intelligent procedure documentation and patient charting (Provation® MD, Provation® Apex and Provation® MultiCaregiver), order set and care plan management (Provation® Order Sets and Provation® Care Plans), and EHR-embedded clinical documentation templates (Provation® Clinic Note). Provation software helps providers increase operational efficiencies, business profitability and regulatory compliance by improving quality, streamlining workflows and enabling insights. Trusted by leading physicians globally, Provation serves nearly 3,500 hospitals, ambulatory surgery centers (ASCs) and medical offices, including 43 of the top 50 U.S. hospitals for gastroenterology (GI) and GI surgery. Provation is headquartered in Minneapolis, MN. For more information about Provation’s solutions, visit provationmedical.com and follow us on Twitter, Facebook and LinkedIn.About ePreopePreop, Inc. (“ePreop”) was founded by a team of independent, board-certified physicians determined to remove the complexity of preoperative screening. The company’s mission is to improve patient safety and outcomes by simplifying the entire surgical encounter. ePreop offers two software platforms: SurgicalValet™ and AnesthesiaValet™. These modular SaaS solutions are accessed as an integrated extension of nearly every major surgical EHR on the market today. The HIPAA compliant tools can also be used on mobile phones, tablets, or desktops. For more information about ePreop solutions, visit epreop.com.About ClearlakeClearlake Capital Group, L.P. is a leading private investment firm founded in 2006. With a sector-focused approach, the firm seeks to partner with world-class management teams by providing patient, long-term capital to dynamic businesses that can benefit from Clearlake’s operational improvement approach, O.P.S.® The firm’s core target sectors are technology, industrials and consumer. Clearlake currently has approximately $25 billion of assets under management and its senior investment principals have led or co-led over 200 investments. For more information on Clearlake, please visit clearlake.com.Clearlake Media Contact
 Lambert & Co.
 Jennifer Hurson
845-507-0571
jhurson@lambert.comAttachmentsProvation_RGB_JPGclearlake hi resCole Heath
Provation
612.215.8175
Cole.Heath@provationmedical.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.